Jason Springs On Selling His First Startup To Roche For $425 Million And Now Bringing Targeted Therapies To Critically Ill Patients

Jason Springs is the co-founder and CEO of Endpoint Health which provides precision medicine and integrated therapies for critical care. The company has already secured $12 million in funding from investors, including Mayfield, AME Cloud Ventures, Wireframe Ventures, and Y Combinator. Prior to this, Jason Springs sold the previous company he cofounded, GeneWEAVE, to Roche in 2015 fo $425 million.